Reactions of N,N′-dicarboxamido-N,N′-dicarboxymethyl-1,2-diaminoethane (EDTA–diamide) with hydrated ruthenium(III) chloride and potassium tetrachloroplatinate(II). Crystal and molecular structures of the pentadentate EDTA–H complex NH4[Ru(EDTA–H)Cl] · 2H2O and the EDTA–imide complex PtCl2[2(HOOCCH2)NCH2CH2NCH2CONHCOCH2] · 2H2O
- 4 December 1998
- journal article
- Published by Elsevier in Polyhedron
- Vol. 18 (1-2) , 49-55
- https://doi.org/10.1016/s0277-5387(98)00266-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Improved understanding in platinium antitumour chemistryChemical Communications, 1996
- Synthesis, Structure and Antitumour Properties of a New1,2‐Propylenediaminetetraacetate‐Ruthenium(III) CompoundMetal-Based Drugs, 1995
- The first isolated antineoplastic Ru(IV) complex: Synthesis and structure of [Cl2(1,2-cyclohexanediaminotetraacetate)Ru]·2H2 OInorganica Chimica Acta, 1994
- Water‐Soluble Ruthenium(III)‐Dimethyl Sulfoxide Complexes:Chemical Behaviour and Pharmaceutical PropertiesMetal-Based Drugs, 1994
- Preparation and Crystal Structure of a Platinum(II) Complex of[CH2N(CH2COOH)CH2CONH2]2, the Hydrolysis Product of an Anti‐TumourBis(3,5‐Dioxopiperazin‐1‐YL)AlkaneMetal-Based Drugs, 1994
- Synthesis of the monooxoruthenium(V) complexes containing the aminopolycarboxylic acid ligands EDTA and PDTA and their reactivities in the oxidation of organic substrates. X-ray crystal structures of K[RuIII(EDTA-H)Cl].cntdot.2H2O and K[RuIII(PDTA-H)Cl].cntdot.0.5H2OInorganic Chemistry, 1992
- Transition Metal Complexes as Drugs and Chemotherapeutic AgentsPublished by Springer Nature ,1989
- Synthesis, molecular structure, and tumor-inhibiting properties of imidazolium trans-bis(imidazole)tetrachlororuthenate(III) and its methyl-substituted derivativesInorganic Chemistry, 1987
- Synthesis, antitumor activity, and x-ray structure of bis(imidazolium) (imidazole)pentachlororuthenate(III), (ImH)2(RuImCl5)Inorganic Chemistry, 1987
- Metal binding by pharmaceuticals. part 2. interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICRF 159 and its inactive homologue ICRF 192Inflammation Research, 1982